297 related articles for article (PubMed ID: 22538522)
1. Drugs for rheumatoid arthritis.
Treat Guidel Med Lett; 2012 May; 10(117):37-44; quiz 2 p following 44. PubMed ID: 22538522
[No Abstract] [Full Text] [Related]
2. Perioperative management of biologic agents used in treatment of rheumatoid arthritis.
Mushtaq S; Goodman SM; Scanzello CR
Am J Ther; 2011 Sep; 18(5):426-34. PubMed ID: 20216205
[TBL] [Abstract][Full Text] [Related]
3. Assessing the value of rheumatoid arthritis treatment alternatives: the potential effect of tumor necrosis factor inhibitors.
Mizutani W
Manag Care Interface; 2003 Mar; 16(3):44-50, 55. PubMed ID: 12715413
[TBL] [Abstract][Full Text] [Related]
4. Putting new disease-modifying antirheumatic drugs into perspective.
Saseen JJ
Pharmacotherapy; 2007 Dec; 27(12):1609-10. PubMed ID: 18041880
[No Abstract] [Full Text] [Related]
5. [Biopharmaceuticals in the treatment of rheumatoid arthritis].
Baslund B; Bendtzen K
Ugeskr Laeger; 2008 Jun; 170(24):2108-10. PubMed ID: 18572481
[TBL] [Abstract][Full Text] [Related]
6. Management of rheumatoid arthritis.
Handa R
Natl Med J India; 2004; 17(3):143-51. PubMed ID: 15253402
[TBL] [Abstract][Full Text] [Related]
7. When is switching warranted among biologic therapies in rheumatoid arthritis?
Reynolds A; Koenig AS; Bananis E; Singh A
Expert Rev Pharmacoecon Outcomes Res; 2012 Jun; 12(3):319-33. PubMed ID: 22812556
[TBL] [Abstract][Full Text] [Related]
8. [Infliximab for therapy of rheumatoid arthritis].
Amano K
Nihon Rinsho; 2005 Jan; 63 Suppl 1():517-20. PubMed ID: 15799410
[No Abstract] [Full Text] [Related]
9. Biologic therapy for early rheumatoid arthritis: the latest evidence.
Castro-Rueda H; Kavanaugh A
Curr Opin Rheumatol; 2008 May; 20(3):314-9. PubMed ID: 18388524
[TBL] [Abstract][Full Text] [Related]
10. [TNF-alpha antibody in rheumatoid arthritis. Efficacy-risk relationship is positively evaluated].
MMW Fortschr Med; 2002 May; 144(20):65. PubMed ID: 12119893
[No Abstract] [Full Text] [Related]
11. Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases.
Taylor PC
Curr Opin Pharmacol; 2010 Jun; 10(3):308-15. PubMed ID: 20172761
[TBL] [Abstract][Full Text] [Related]
12. Dermatomyositis in patients with rheumatoid arthritis during adalimumab therapy.
Nagashima T; Minota S
J Rheumatol; 2011 Mar; 38(3):574; author reply 575. PubMed ID: 21362792
[No Abstract] [Full Text] [Related]
13. [Remission--therapy goal in rheumatoid arthritis].
Z Rheumatol; 2007 Feb; 66(1):2 p following 87. PubMed ID: 17896425
[No Abstract] [Full Text] [Related]
14. [TNF antagonists in therapy of rheumatoid arthritis].
Oberpichler-Schwenk H
Med Monatsschr Pharm; 1999 Nov; 22(11):334-9. PubMed ID: 10596266
[No Abstract] [Full Text] [Related]
15. Biologic therapy for rheumatoid arthritis.
Klippel JH
N Engl J Med; 2000 Nov; 343(22):1640-1. PubMed ID: 11096174
[No Abstract] [Full Text] [Related]
16. Tumor necrosis factor-alpha blockade and the risk of vasculitis.
Guillevin L; Mouthon L
J Rheumatol; 2004 Oct; 31(10):1885-7. PubMed ID: 15468348
[No Abstract] [Full Text] [Related]
17. The appearance of pustular psoriasis during antitumor necrosis factor therapy.
Goncalves DP; Laurindo I; Scheinberg MA
J Clin Rheumatol; 2006 Oct; 12(5):262. PubMed ID: 17023816
[No Abstract] [Full Text] [Related]
18. Adalimumab for rheumatoid arthritis?
Ebell M; Kripke C
Am Fam Physician; 2006 Feb; 73(3):435-6. PubMed ID: 16479667
[No Abstract] [Full Text] [Related]
19. TNF-alpha antagonists and other recombinant proteins for the treatment of rheumatoid arthritis.
Brasington R
J Hand Surg Am; 2009 Feb; 34(2):349-50. PubMed ID: 19135810
[No Abstract] [Full Text] [Related]
20. Should anti-tumor necrosis factor-alpha be the first therapy for rheumatoid vasculitis?
Garcia-Porrua C; Gonzalez-Gay MA; Quevedo V
J Rheumatol; 2006 Feb; 33(2):433; author reply 433-4. PubMed ID: 16465676
[No Abstract] [Full Text] [Related]
[Next] [New Search]